logo
Plus   Neg
Share
Email

FDA Approves Abbott's NexGen Gallant ICD, CRT-D Devices - Quick Facts

Abbott (ABT) announced that the U.S. FDA has approved the company's next-generation Gallant implantable cardioverter defibrillator or ICD and cardiac resynchronization therapy defibrillator or CRT-D devices.

The company noted that the devices bring new benefits to patients with heart rhythm disorders, including a patient-preferred design without compromising battery longevity and MRI compatibility.

In addition, the new devices offer Bluetooth technology and a new patient smartphone app for improved remote monitoring, allowing for increased patient/physician engagement and streamlined communications.

The Gallant system received CE Mark for use across Europe earlier this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MWE Investments is recalling dual fuel portable generators citing fire risk, according to the U.S. Consumer Product Safety Commission. The recall involves about 7,500 units of Westinghouse WGen5300DFv Dual Fuel Portable Generators and Westinghouse iGen4500DF Dual Fuel Inverter Portable Generators. According to the agency, the dual fuel portable generators can leak fuel. Apple Inc. (AAPL) will launch an online store in India on September 23, offering the tech giant's full range of products and support directly to customers across the country for the first time. U.S. retail sales continued to recover from the coronavirus pandemic in August, showing a slight improvement from July and larger gains than last year, the National Retail Federation or NRF said. However, the pace of growth slowed from July. The NRF said in a statement that August retail sales edged up 0.1 percent seasonally adjusted from July and rose 5.6 percent unadjusted year-over-year.
Follow RTT